Cybin (HELP) Net Income (2020 - 2025)
Cybin (HELP) posted quarterly Net Income of -$42.7 million for Q4 2025, down 465.4% year-on-year from $11.7 million in Q4 2024, and down 26.53% on a QoQ basis from -$33.7 million in Q3 2025.
Cybin (HELP) Net Income (2020 - 2025) Analysis & Trends
Cybin (HELP) has reported Net Income for 6 consecutive years, with -$42.7 million the latest figure, recorded in Q4 2025.
- Quarterly Net Income fell 465.4% year-over-year to -$42.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$101.0 million (down 67.47% YoY) and the FY2026 annual result came in at -$147.8 million, down 74.01% from the prior year.
- Net Income declined to -$42.7 million in Q4 2025 per HELP's latest filing, from -$33.7 million in the prior quarter.
- Over the last five years, Net Income for HELP reached as high as $32.0 million in Q1 2022 and fell as low as -$42.7 million in Q4 2025.
- A 5-year average of -$12.2 million and a median of -$10.8 million in 2024 frame the typical range for Net Income.
- Annual changes were most pronounced in 2021 — Net Income sank 600.72% — and 2024, when it surged 66.13%.
- Year by year, Net Income stood at -$13.7 million in 2021, then jumped by 42.04% to -$7.9 million in 2022, then tumbled by 181.52% to -$22.3 million in 2023, then surged by 66.13% to -$7.5 million in 2024, then slumped by 465.4% to -$42.7 million in 2025.
- According to Business Quant data, Net Income over the past three periods registered -$42.7 million, -$33.7 million, and -$24.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42.67 Mn |
| Sep 30, 2025 | -33.72 Mn |
| Jun 30, 2025 | -24.61 Mn |
| Dec 31, 2024 | -7.55 Mn |
| Sep 30, 2024 | -41.92 Mn |
| Jun 30, 2024 | -10.84 Mn |
| Dec 31, 2023 | -22.28 Mn |
| Sep 30, 2023 | -8.87 Mn |
| Jun 30, 2023 | -10.80 Mn |
| Feb 28, 2023 | 8.11 Mn |
| Dec 31, 2022 | -7.91 Mn |
| Sep 30, 2022 | -7.65 Mn |
| May 31, 2022 | 4.55 Mn |
| Feb 28, 2022 | 32.01 Mn |
| Dec 31, 2021 | -13.65 Mn |
| Sep 30, 2021 | -13.99 Mn |
| Jun 30, 2021 | -11.97 Mn |
| Mar 31, 2021 | -5.24 Mn |
| Dec 31, 2020 | -8.76 Mn |
| Sep 30, 2020 | -2.00 Mn |